http://www.news-medical.net/news/20120918/Compelling-data-from-two-ITS-Flunisyn-Phase-I-clinical-trials-against-multiple-strains-of-influenza-A.aspx
Thanks
Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment